183 related articles for article (PubMed ID: 32746448)
1. Genetic variant burden and adverse outcomes in pediatric cardiomyopathy.
Burstein DS; Gaynor JW; Griffis H; Ritter A; Connor MJO; Rossano JW; Lin KY; Ahrens-Nicklas RC
Pediatr Res; 2021 May; 89(6):1470-1476. PubMed ID: 32746448
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.
Bourfiss M; van Vugt M; Alasiri AI; Ruijsink B; van Setten J; Schmidt AF; Dooijes D; Puyol-Antón E; Velthuis BK; van Tintelen JP; Te Riele ASJM; Baas AF; Asselbergs FW
Circ Genom Precis Med; 2022 Dec; 15(6):e003704. PubMed ID: 36264615
[TBL] [Abstract][Full Text] [Related]
3. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.
Jansen M; de Brouwer R; Hassanzada F; Schoemaker AE; Schmidt AF; Kooijman-Reumerman MD; Bracun V; Slieker MG; Dooijes D; Vermeer AMC; Wilde AAM; Amin AS; Lekanne Deprez RH; Herkert JC; Christiaans I; de Boer RA; Jongbloed JDH; van Tintelen JP; Asselbergs FW; Baas AF
JACC Heart Fail; 2024 Jan; 12(1):134-147. PubMed ID: 37565978
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification.
Quiat D; Witkowski L; Zouk H; Daly KP; Roberts AE
J Am Heart Assoc; 2020 Jun; 9(11):e016195. PubMed ID: 32458740
[TBL] [Abstract][Full Text] [Related]
5. Genetic Testing in Pediatric Cardiomyopathy.
Ellepola CD; Knight LM; Fischbach P; Deshpande SR
Pediatr Cardiol; 2018 Mar; 39(3):491-500. PubMed ID: 29188317
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of a Phenotype-Enhanced
Mattivi CL; Bos JM; Bagnall RD; Nowak N; Giudicessi JR; Ommen SR; Semsarian C; Ackerman MJ
Circ Genom Precis Med; 2020 Oct; 13(5):453-459. PubMed ID: 32894683
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy.
Aljeaid D; Sanchez AI; Wakefield E; Chadwell SE; Moore N; Prada CE; Zhang W
Am J Med Genet A; 2019 Apr; 179(4):608-614. PubMed ID: 30762279
[TBL] [Abstract][Full Text] [Related]
8. Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes.
Field E; Norrish G; Acquaah V; Dady K; Cicerchia MN; Ochoa JP; Syrris P; McLeod K; McGowan R; Fell H; Lopes LR; Cervi E; Kaski JPP
J Med Genet; 2022 Aug; 59(8):768-775. PubMed ID: 34400558
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis.
Seidel F; Holtgrewe M; Al-Wakeel-Marquard N; Opgen-Rhein B; Dartsch J; Herbst C; Beule D; Pickardt T; Klingel K; Messroghli D; Berger F; Schubert S; Kühnisch J; Klaassen S
Circ Genom Precis Med; 2021 Aug; 14(4):e003250. PubMed ID: 34213952
[TBL] [Abstract][Full Text] [Related]
10. Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service.
Trachoo O; Yingchoncharoen T; Ngernsritrakul T; Iemwimangsa N; Panthan B; Klumsathian S; Srisukh S; Mukdadilok A; Phusanti S; Charoenyingwattana A; Chareonsirisuthigul T; Chantratita W; Tangcharoen T
PLoS One; 2022; 17(9):e0267770. PubMed ID: 36166435
[TBL] [Abstract][Full Text] [Related]
11. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
[TBL] [Abstract][Full Text] [Related]
12. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
[TBL] [Abstract][Full Text] [Related]
13. The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.
McGurk KA; Zhang X; Theotokis P; Thomson K; Harper A; Buchan RJ; Mazaika E; Ormondroyd E; Wright WT; Macaya D; Pua CJ; Funke B; MacArthur DG; Prasad SK; Cook SA; Allouba M; Aguib Y; Yacoub MH; O'Regan DP; Barton PJR; Watkins H; Bottolo L; Ware JS
Am J Hum Genet; 2023 Sep; 110(9):1482-1495. PubMed ID: 37652022
[TBL] [Abstract][Full Text] [Related]
14. Hereditary Hypertrophic Cardiomyopathy in Children and Young Adults-The Value of Reevaluating and Expanding Gene Panel Analyses.
Fernlund E; Kissopoulou A; Green H; Karlsson JE; Ellegård R; Årstrand HK; Jonasson J; Gunnarsson C
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33302605
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
Kaski JP; Norrish G; Gimeno Blanes JR; Charron P; Elliott P; Tavazzi L; Tendera M; Laroche C; Maggioni AP; Baban A; Khraiche D; Ziolkowska L; Limongelli G; Ojala T; Gorenflo M; Anastasakis A; Mostafa S; Caforio ALP;
Eur Heart J; 2024 Apr; 45(16):1443-1454. PubMed ID: 38427064
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic relevance of using large gene panels in the genetic testing of patients with dilated cardiomyopathy.
Stroeks SLVM; Hellebrekers D; Claes GRF; Krapels IPC; Henkens MHTM; Sikking M; Vanhoutte EK; Helderman-van den Enden A; Brunner HG; van den Wijngaard A; Verdonschot JAJ
Eur J Hum Genet; 2023 Jul; 31(7):776-783. PubMed ID: 37198425
[TBL] [Abstract][Full Text] [Related]
17. Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy.
Khan RS; Pahl E; Dellefave-Castillo L; Rychlik K; Ing A; Yap KL; Brew C; Johnston JR; McNally EM; Webster G
J Am Heart Assoc; 2022 Jan; 11(1):e022854. PubMed ID: 34935411
[TBL] [Abstract][Full Text] [Related]
18. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
19. Investigation of de novo variation in pediatric cardiomyopathy.
Parrott A; Khoury PR; Shikany AR; Lorts A; Villa CR; Miller EM
Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):116-123. PubMed ID: 31912959
[TBL] [Abstract][Full Text] [Related]
20. Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study.
Ravi R; Fernandes Silva L; Vangipurapu J; Maria M; Raivo J; Helisalmi S; Laakso M
Metabolites; 2022 May; 12(5):. PubMed ID: 35629941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
